Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Eurogin
 

08 - 11 February 2023

Bilbao, Spain

  • 
  • Scientific Information
    • Message from the Chairman of the Scientific Committee
    • Previous Congress Presidents
    • Previous Congresses
  • Program & CME
    • Program Overview
    • Download Program 2022
    • CME Accreditation
  • Registration
    • SOD Add-on
  • Abstracts & Posters
    • Abstracts EUROGIN 2022
  • Sponsorship & Exhibition
    • Sponsors and Exhibitors 2022
    • Exhibitors Information
    • Previous Meeting Reports
  • Congress Information
    • Contact us
    • Newsletter
    • Post Meeting Report 2022
    • Picture Gallery 2022

Colposcopy Course
April 10, 2022 • Room 16a

Coordinators: J. Bornstein (Israel) - A. Singer (UK)

Welcome to the EUROGIN Colposcopy course. Taking care of cervical precancer has evolved significantly in recent years. However, the basis remains – Colposcopy. Performing colposcopy necessitates knowledge and experience. In this course you will learn the fundamentals of the use of the colposcope and essentials of diagnosing and treating precancerous cervical lesions.
The EUROGIN course has traditionally been led by Professor Albert Singer, and we have the great pleasure of having him with us again this year, co-sharing the leadership of this course with Professor Jacob Bornstein, who headed the IFCPC Nomenclature committee that produced the contemporary colposcopy terminology.
Colposcopy is the visual examination of the epithelial cervix using either uni - or binocular vision. Specific abnormalities associated with both squamous and glandular precancer can be identified especially after the application of a 5% acetic acid solution. After this application, the abnormalities become visible as a result to changes in the epithelium and blood vessels in the stroma.
These changes occur within an area of the cervix called the transformation zone, an area bounded by the junction of vaginal epithelium and the glandular epithelium arising from the endocervix (canal). Within this area a change occurs in which glandular epithelium changes to squamous by a process of transformation, called metaplasia. The upper border of this metaplastic change is called the new squamo-columnar junction. The inability to see this junction means that abnormality may exist higher up in the endo cervix. A sample of any abnormality within the transformation zone can be taken by a simple punch biopsy.
Colposcopy is an essential part of the diagnosis and treatment of cervical precancer. It is indicated in the presence of abnormal cytology or in the finding of certain types of HPV and also when there are clinical symptoms and signs of the early invasive cancer.

Educational Objectives:

Upon completion of this educational activity, participants should be able to:

  • Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix.
  • Define the pathophysiology of lower genital tract neoplasia, including the role of HPV in preinvasive and invasive diseases of the cervix.
  • Define the IFCPC colposcopy terminology.
  • Recognize the diagnostic characteristics of cervical abnormalities (minor-grade and major-grade cervical lesions as well as glandular lesions and cervical cancer) on cytologic, colposcopic, and histologic exam;
  • Interpret and correlate cytologic, colposcopic, and histologic results.
  • Describe treatment options to include cryosurgery and large loop excision of the transformation zone (LLETZ) of the cervix.
  • Provide appropriate patient education and support.

Welcome / Registration

Part A

Chair: A. Singer (UK) - J. Bornstein (Israel)

8.30 - 10.00

Opening

Singer A. (UK)

CC A-1

The normal cervix and the colposcopy examination

Singer A. (UK)

CC A-2

Pathology, cytology and dual staining for colposcopists

Bergeron C. (France)

CC A-3

Colposcopy of “abnormal” cervix, colposcopic terminology, risk-based management consensus guidelines

Bornstein J. (Israel)

Part B

Chair: A. Singer (UK) - J. Bornstein (Israel)

10.30 - 12.00

CC B-1

Better management of abnormal screening findings - the value of biomarkers in screening algorithms

Bonde J. (Denmark)

CC B-2

Treatment of cervical precancer, complications

Bornstein J. (Israel)

CC B-3

Interactive session (what is your diagnosis)

A. Singer (UK)

CC B-4

Summary

Bornstein J. (Israel)

ABOUT EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

ETHICAL COMPLIANCE

EUROVIR, owning the trademark EUROGIN, is a Trusted Partner of Ethical MedTech.

USEFUL LINKS

  • Registration Information |
  • EUROGIN PORTAL |
  • EUROGIN FRANCE |
  • Previous events |
  • Related Events / Partnerships |
  • Legal Information |
  • Cancellation Policy |
  • Delegates Terms & Conditions
Informa Markets

Copyright © 2022. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions